VAERS reports by lot

GSK Hepatitis A lot 2X2EJ: VAERS reports

23 VAERS reports list lot 2X2EJ as a GSK Hepatitis A vaccine, received between 2023-01-27 and 2024-12-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological538%
Respiratory215%
Dermatological (non-injection-site)215%
Allergic / Anaphylactic18%
Gastrointestinal18%
Psychiatric / Neuropsychiatric18%
Injection-site / Local reaction18%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan4
Georgia3
Maryland2
Florida2
Virginia2
Texas1
Oregon1
Connecticut1
New Mexico1
Alabama1
North Carolina1
Massachusetts1

Reports by month received

2023-011
2023-022
2023-033
2023-045
2023-053
2023-062
2023-071
2024-022
2024-081
2024-112
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.